Proposed Collection; 60-Day Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH)

• Published date: 10 April 2024
• Record Number: 2024-07547
• Court: National Institutes Of Health

25275

Federal Register / Vol. 89, No. 70 / Wednesday, April 10, 2024 / Notices

Respondent entered into a Voluntary

Settlement Agreement (Agreement) and

voluntarily agreed to the following:

(1) Respondent will have his research

supervised for a period of five (5) years

beginning on March 24, 2024 (the

‘‘Supervision Period’’). Prior to the

submission of an application for PHS

support for a research project on which

Respondent’s participation is proposed

and prior to Respondent’s participation

in any capacity in PHS-supported

research, Respondent will submit a plan

for supervision of Respondent’s duties

to ORI for approval. The supervision

plan must be designed to ensure the

integrity of Respondent’s research.

Respondent will not participate in any

PHS-supported research until such a

supervision plan is approved by ORI.

Respondent will comply with the

agreed-upon supervision plan.

(2) The requirements for Respondent’s

supervision plan are as follows:

i. A committee of 2–3 senior faculty

members at the institution who are

familiar with Respondent’s field of

research, but not including

Respondent’s supervisor or

collaborators, will provide oversight and

guidance for a period of five (5) years

from the effective date of the

Agreement. The committee will review

primary data from Respondent’s

laboratory on a quarterly basis and

submit a report to ORI at six (6) month

intervals setting forth the committee

meeting dates and Respondent’s

compliance with appropriate research

standards and confirming the integrity

of Respondent’s research.

ii. The committee will conduct an

advance review of each application for

PHS funds, or report, manuscript, or

abstract involving PHS-supported

research in which Respondent is

involved. The review will include a

discussion with Respondent of the

primary data represented in those

documents and will include a

certification to ORI that the data

presented in the proposed application,

report, manuscript, or abstract are

supported by the research record.

(3) During the Supervision Period,

Respondent will ensure that any

institution employing him submits, in

conjunction with each application for

PHS funds, or report, manuscript, or

abstract involving PHS-supported

research in which Respondent is

involved, a certification to ORI that the

data provided by Respondent are based

on actual experiments or are otherwise

legitimately derived and that the data,

procedures, and methodology are

accurately reported and not plagiarized

in the application, report, manuscript,

or abstract.

(4) If no supervision plan is provided

to ORI, Respondent will provide

certification to ORI at the conclusion of

the Supervision Period that his

participation was not proposed on a

research project for which an

application for PHS support was

submitted and that he has not

participated in any capacity in PHS-

supported research.

(5) During the Supervision Period,

Respondent will exclude himself

voluntarily from serving in any advisory

or consultant capacity to PHS including,

but not limited to, service on any PHS

advisory committee, board, and/or peer

review committee.

(6) Respondent will request that the

following paper be corrected or

retracted:

•Cell. 2019 Oct 3;179(2):373–

391.e27. doi: 10.1016/j.cell.2019.09.004.

Respondent will copy ORI and the

Research Integrity Officer at UCSD on

the correspondence with the journal.

Dated: April 4, 2024.

Sheila Garrity,

Director, Office of Research Integrity, Office

of the Assistant Secretary for Health.

[FR Doc. 2024–07575 Filed 4–9–24; 8:45 am]

BILLING CODE 4150–31–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Proposed Collection; 60-Day Comment

Request; Generic Clearance for the

Collection of Qualitative Feedback on

Agency Service Delivery (NIH)

AGENCY

: National Institutes of Health,

HHS.

ACTION

: Notice.

SUMMARY

: In compliance with the

requirement of the Paperwork

Reduction Act of 1995 to provide

opportunity for public comment on

proposed data collection projects,

National Institutes of Health (NIH) will

publish periodic summaries of proposed

projects to be submitted to the Office of

Management and Budget (OMB) for

review and approval.

DATES

: Comments regarding this

information collection are best assured

of having their full effect if received

within 60 days of the date of this

publication.

FOR FURTHER INFORMATION CONTACT

: To

obtain a copy of the data collection

plans and instruments, submit

comments in writing, or request more

information on the proposed project,

contact: Ms. Mikia P. Currie, Chief

Project Clearance Officer, Office of

Policy for Extramural Research

Administration, 6705 Rockledge Drive,

Suite 350, Bethesda, Maryland, 20892 or

call non-toll-free number (301) 435–

0941 or email your request, including

your address to: curriem@mail.nih.gov.

Formal requests for additional plans and

instruments must be requested in

writing.

SUPPLEMENTARY INFORMATION

: Section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995 requires: written

comments and/or suggestions from the

public and affected agencies are invited

to address one or more of the following

points: (1) Whether the proposed

collection of information is necessary

for the proper performance of the

function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) Ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Proposed Collection Title: Generic

Clearance for the Collection of

Qualitative Feedback on Agency Service

Delivery, 0925–EXTENSION, exp., date

6/30/2024, National Institutes of Health

(NIH).

Need and Use of Information

Collection: We are not requesting

changes for this submission. The

proposed information collection

provides a means to garner qualitative

customer and stakeholder feedback in

an efficient, timely manner, in

accordance with the Administration’s

commitment to improving service

delivery. By qualitative feedback we

mean information that provides useful

insights on perceptions and opinions.

This information, however, is not

statistical surveys that yield quantitative

results, which can be generalized to the

population of study. This feedback will

provide information about NIH’s

customer or stakeholder perceptions,

experiences, and expectations, provide

an early warning of issues with service,

or focus attention on areas where

communication, training, or changes in

operations might improve delivery of

products or services. These collections

will allow for ongoing, collaborative,

and actionable communications

between NIH and its customers and

stakeholders. It will also allow feedback

VerDate Sep<11>2014 18:10 Apr 09, 2024 Jkt 262001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\10APN1.SGM 10APN1

ddrumheller on DSK120RN23PROD with NOTICES1

25276

Federal Register / Vol. 89, No. 70 / Wednesday, April 10, 2024 / Notices

to contribute directly to the

improvement of program management.

The solicitation of feedback will target

areas such as: timeliness,

appropriateness, accuracy of

information, courtesy, efficiency of

service delivery, and resolution of

issues with service delivery. Responses

will be assessed to plan and inform

efforts to improve or maintain the

quality of service offered to the public.

If this information is not collected, vital

feedback from customers and

stakeholders on NIH’s services will be

unavailable.

NIH will only submit a collection for

approval under this generic clearance if

it meets the following:

•The collections are voluntary;

•The collections are low-burden for

respondents (based on considerations of

total burden hours, total number of

respondents, or burden-hours per

respondent) and are low-cost for both

the respondents and the Federal

Government;

•The collections are non-

controversial and do not raise issues of

concern to other Federal agencies;

•Any collection is targeted to the

solicitation of opinions from

respondents who have experience with

the program or may have experience

with the program in the near future;

•Personally Identifiable information

is collected only to the extent necessary

and is not retained;

•Information gathered will be used

only internally for general service

improvement and program management

purposes and is not intended for release

outside of the agency;

•Information gathered will not be

used for the purpose of substantially

informing influential policy decisions;

and

•Information gathered will yield

qualitative information; the collections

will not be designed or expected to

yield statistically reliable results or used

as though the results are generalizable to

the population of study.

Feedback collected under this generic

clearance provides useful information,

but it does not yield data that can be

generalized to the overall population.

This type of generic clearance for

qualitative information will not be used

for quantitative information collections

that are designed to yield reliably

actionable results, such as monitoring

trends over time or documenting

program performance. Such data uses

require more rigorous designs that

address: the target population to which

generalizations will be made, the

sampling frame, the sample design

(including stratification and clustering),

the precision requirements or power

calculations that justify the proposed

sample size, the expected response rate,

methods for assessing potential non-

response bias, the protocols for data

collection, and any testing procedures

that were or will be undertaken prior to

fielding the study. Depending on the

degree of influence the results are likely

to have, such collections may still be

eligible for submission for other generic

mechanisms that are designed to yield

quantitative results. As a general matter,

information collections will not result

in any new system of records containing

privacy information and will not ask

questions of a sensitive nature, such as

sexual behavior and attitudes, religious

beliefs, and other matters that are

commonly considered private.

OMB approval is requested for 3

years. There are no costs to respondents

other than their time. The total

estimated annualized burden hours are

49,333.

E

STIMATED

A

NNUALIZED

B

URDEN

H

OURS

Type of collection Number of

respondents

Number of

responses per

respondent

Average time

per response

(in hours)

Total annual

burden hours

Customer Satisfaction/Feedback Surveys ....................................................... 1,000 1 30/60 500

In-Depth Interviews (IDIs) or Small Discussion Groups .................................. 1,000 1 90/60 1,500

Focus Groups .................................................................................................. 1,000 1 90/60 1,500

Usability and Pilot Testing ............................................................................... 150,000 1 5/60 12,500

Conference/Training—Pre-and Post-Surveys .................................................. 100,000 2 10/60 33,333

Total .......................................................................................................... 253,000 353,000 ........................ 49,333

Dated: April 3, 2024.

Lawrence A. Tabak,

Principal Deputy Director, National Institutes

of Health.

[FR Doc. 2024–07547 Filed 4–9–24; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 1009 of the

Federal Advisory Committee Act, as

amended, notice is hereby given of the

following meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel;

Hispanic Community Health Study—Study

of Latinos (HCHS–SOL) Field Centers.

Date: May 2, 2024.

Time: 11:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate contract

proposals.

Place: National Institutes of Health,

Rockledge I, 6705 Rockledge Drive, Bethesda,

MD 20892 (Virtual Meeting).

Contact Person: Susan Wohler Sunnarborg,

Ph.D., Scientific Review Officer, Office of

Scientific Review/DERA, National, Heart,

Lung, and Blood Institute, National Institutes

of Health, 6705 Rockledge Drive, Room 208–

Z, Bethesda, MD 20892, (301) 827–7987,

susan.sunnarborg@nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: April 4, 2024.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory

Committee Policy.

[FR Doc. 2024–07543 Filed 4–9–24; 8:45 am]

BILLING CODE 4140–01–P

VerDate Sep<11>2014 18:10 Apr 09, 2024 Jkt 262001 PO 00000 Frm 00047 Fmt 4703 Sfmt 9990 E:\FR\FM\10APN1.SGM 10APN1

ddrumheller on DSK120RN23PROD with NOTICES1